A twice-daily or a three-times-daily tegafur-uracil and leucovorin calcium regimen as adjuvant therapy in patients with resected colorectal cancer: A phase III study.
Kazuya Iwamoto(Osaka Police Hospital), Hidetoshi Eguchi(Osaka Gakuin University), Masayuki Ohue(Hyogo Medical University), Norikatsu Miyoshi(Osaka International Cancer Institute), Tsunekazu Mizushima(The University of Osaka), Yuichiro� Doki(Osaka Gakuin University), Taishi Hata(The University of Osaka), Yuko Ohno(Hyogo Prefectural Nishinomiya Hospital), Hidekazu Takahashi(Boston Medical Center), Mitsuyoshi Tei(Osaka Rosai Hospital), Chu Matsuda(Osaka International Cancer Institute), Hiroyoshi Takemoto(Kinki Central Hospital), Masakazu Miyake(Osaka National Hospital), Kohei Murata(Suita Municipal Hospital), Yujiro Fujie(The University of Osaka), Tatsushi Shingai(Kinki Central Hospital), Masakazu Ikenaga(Osaka National Hospital), Mamoru Uemura(Osaka International Cancer Institute)
Cited by 0
Related Papers
Overexpression of miR-200c Induces Chemoresistance in Esophageal Cancers Mediated Through Activation of the Akt Signaling Pathway
|Clinical Cancer Research|2011|245
Implications of Nectin-like Molecule-2/IGSF4/RA175/SgIGSF/TSLC1/SynCAM1 in Cell-Cell Adhesion and Transmembrane Protein Localization in Epithelial Cells
|Journal of Biological Chemistry|2003|231
γ-Aminobutyric Acid (GABA) Stimulates Pancreatic Cancer Growth through Overexpressing GABAA Receptor π Subunit
|Cancer Research|2007|173